ORIGINAL ARTICLE
Year : 2021 | Volume
: 5 | Issue : 4 | Page : 446--450
Computational bioprospecting of andrographolide derivatives as potent cyclooxygenase-2 inhibitors
Somdutt Mujwar
Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
Correspondence Address:
Somdutt Mujwar
Institute of Pharmaceutical Research, GLA University, Mathura - 281 406, Uttar Pradesh
India
Background: Inflammation is a protective response of the human body that still causes a high level of discomfort because of the associated pain and other inflammatory reactions. Nonsteroidal anti-inflammatory drugs (NSAIDs) have certain associated severe side-effects such as hepatotoxicity. Thus, there is an urgent need to develop a novel anti-inflammatory agent to counter the associated problems with the existing NSAIDs. Methods: The herbal sources are a very vast treasure for exploring potential leads for the development of novel therapeutic agents to counter the existing healthcare problems for the welfare of humankind. Thus, in the current experimental study, the author has tried to develop some of the novel andrographolide analogs as cyclooxygenase-2 (COX-2) inhibitors by using bioisosteric substitutions. Results: The newly developed andrographolide derivatives have a high affinity for the human COX-2 enzyme, an optimized pharmacokinetic profile as well as being free from any associated toxic effects. Conclusion: The andrographolide derivatives as COX-2 inhibitors are supposed to be free from the side effects associated with NSAIDs with an optimized pharmacokinetic profile.
How to cite this article:
Mujwar S. Computational bioprospecting of andrographolide derivatives as potent cyclooxygenase-2 inhibitors.Biomed Biotechnol Res J 2021;5:446-450
|
How to cite this URL:
Mujwar S. Computational bioprospecting of andrographolide derivatives as potent cyclooxygenase-2 inhibitors. Biomed Biotechnol Res J [serial online] 2021 [cited 2023 Jun 9 ];5:446-450
Available from: https://www.bmbtrj.org/article.asp?issn=2588-9834;year=2021;volume=5;issue=4;spage=446;epage=450;aulast=Mujwar;type=0 |
|
